Page last updated: 2024-11-05

tolbutamide and Precancerous Conditions

tolbutamide has been researched along with Precancerous Conditions in 1 studies

Tolbutamide: A sulphonylurea hypoglycemic agent with actions and uses similar to those of CHLORPROPAMIDE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p290)
tolbutamide : An N-sulfonylurea that consists of 1-butylurea having a tosyl group attached at the 3-position.

Precancerous Conditions: Pathological conditions that tend eventually to become malignant.

Research Excerpts

ExcerptRelevanceReference
"A subsequent study of 301 patients with NIDDM and 151 healthy control subjects revealed no additional mutations at codons 148, 497, or 844."1.29Identification of four amino acid substitutions in hexokinase II and studies of relationships to NIDDM, glucose effectiveness, and insulin sensitivity. ( Bjørbaek, C; Clausen, JO; Echwald, SM; Granner, DK; Hansen, T; Pedersen, O; Printz, RL; Vestergaard, H; Zierath, JR, 1995)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Echwald, SM1
Bjørbaek, C1
Hansen, T1
Clausen, JO1
Vestergaard, H1
Zierath, JR1
Printz, RL1
Granner, DK1
Pedersen, O1

Other Studies

1 other study available for tolbutamide and Precancerous Conditions

ArticleYear
Identification of four amino acid substitutions in hexokinase II and studies of relationships to NIDDM, glucose effectiveness, and insulin sensitivity.
    Diabetes, 1995, Volume: 44, Issue:3

    Topics: Adult; Alleles; Amino Acid Sequence; Anthropometry; Base Sequence; Blood Glucose; Body Mass Index; C

1995